Prevention of contrast medium-induced renal vasospasm by phosphodiesterase inhibition

Investigative Radiology

Volumn 33, Issue 12, 1998, Pages 858-862

  Drescher, Peter ^a   Knes, Jane M ^b   Madsen, Paul O ^c  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Contrast media; Phosphodiesterase inhibitor; Renal vasospasm

Indexed keywords

DIPYRIDAMOLE; IODIXANOL; IOPAMIDOL; MEGLUMINE DIATRIZOATE; MEGLUMINE DIATRIZOATE PLUS SODIUM DIATRIZOATE; PAPAVERINE; PHOSPHODIESTERASE INHIBITOR; POTASSIUM CHLORIDE; ROLIPRAM; THEOPHYLLINE; TREQUINSIN; VINPOCETINE; VISIPAQUE 320; ZARDAVERINE;

ANIMAL TISSUE; ARTERY SPASM; ARTICLE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RABBIT; RENAL ARTERY;

EID: 0032471625     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-199812000-00003     Document Type: Article

References (28)

1. Cronin RE. Radiocontrast media-induced acute renal failure. In: Schrier RW, Gottschalk CW, ed. Diseases of the Kidney, 5th edition. Boston, MA: Little, Brown, and Co. 1992;1187-1201.
2. Larson TS, Hudson K, Mertz, JI, Romero JC, Knox FG. Renal vasoconstrictive response to contrast medium. J Lab Clin Med 1983; 101:385-391.
3. Morris TW, Katzberg RW, Fischer HW. A comparison of the hemodynamic responses to metrizamide and meglumine sodium diatrizoate in canine renal angiography. Invest Radiol 1987;13: 74-78.
4. Sherwood T, Lavender JP. Does renal blood flow rise or fall in response to diatrizoate. Invest Radiol 1969;4:327-328.
5. Talner LB, Davidson AJ. Renal hemodynamic effects of contrast media. Invest Radiol 1968;3:310-317.
6. 2+]i smooth muscle. Ann Rev Physiol 1989;51:315-329.
7. 2+ and cyclic AMP signalling system in smooth muscle. Cell Signal 1991;3:371-385.
8. 2+ and cAMP messenger system in regulation of airway smooth muscle contraction. Am J Physiol 1990;258:L279-L288.
9. Beavo JA. Multiple PDE isozymes: Background nomenclature and implications. In: Beavo JA, Houslay MD, eds. Cyclic Nucleotide PDEs: Structure Regulation and Drug Action. New York: Wylie, 1990:3-15.
10. Thompson WJ. Cyclic nucleotide phosphodiesterase: Pharmacology, biochemistry, and function. Pharmacol Ther 1991;51:13-33.
11. Cantley LG, Spokes K, Clark B, McMahon EG, Carter J, Epstein FH. Role of endothelin and prostaglandins in radiocontrast-induced renal artery constriction. Kidney Int 1993;44:1217-1223.
12. Rauch D, Drescher P, Pereira FJ, Knes JM, Will JA, Madsen PO. Comparison of iodinated contrast media induced renal vasoconstriction in human, rabbit, dog, and pig arteries. Invest Radiol 1997;32:315-319.
13. Lincoln TM, Cornwell TL. Toward an understanding of the mechanism of action of cyclic AMP and cyclic GMP in smooth muscle relaxation. Blood Vessels 1991;28:129-137.
14. Rodbell M, Birnbaumer L, Pohl SL, Krans HM. The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. An obligatory role of guanyl nucleotides in glucagon action. J Biol Chem 1971;246:1877-1882.
15. Neer EJ, Chapman DE. Role of G protein subunits shown in transmembrane signalling. Nature 1989;333:129-134.
16. Sonnenburg WK, Beavo JA. Cyclic GMP and regulation of cyclic nucleotide hydrolysis. Adv Pharmacol 1994;26:87-114.
17. Landsberg KF, Vaughan LM, Heffner JE. The effect of theophylline on respiratory muscle contractility and fatigue. Pharmacotherapy 1990;10:271-279.
18. Rall TW. Evolutions of the mechanisms of action of methylxanthines from calcium mobilizers to antagonists of adenosine receptors. Pharmacol 1982;24:277-287.
19. Lohmann SM, Meich RP, Butcher FR. Effects of isoproterenol, theophylline, and carbachol on nucleotide levels and relaxation of bovine tracheal smooth muscle. Biochem Biophys Acta 1977;499: 238-250.
20. Bolton TB. Mechanism of action of transmitters and others substances on smooth muscle. Physiol Rev 1979;59:606-718.
21. Huddart H, Langton PD, Saad KH. Inhibition by papaverine of calcium movements and tension in the smooth muscles of the rat vas deferens and urinary bladder. J Physiol 1984;349:183-194.
22. Nicholson CD, Challiss RAJ, Shadid M. Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. Trends Pharmacol Sci 1991;12:19-27.
23. Bode DC, Kanter JR, Brunton LL. Cellular distribution of phosphodiesterase isoforms in rat cardiac tissue. Circ Res 1991;68:1070-1079.
24. Marcus R, Grant BF. Parathyroid hormones induces a calmodulin dependent alteration in phosphodiesterase activity of the rat kidney. Endocrinology 1983;112:1065-1069.
25. Malta E. Biphasic relaxant curves to glyceryl trinitrate in rat aortic rings. Evidence of two mechanisms of action. Naunyn-Schmiedeberg's Arch Pharmacol 1989;339:236-243.
26. Techel D, Braumann T. Determination of cyclic nucleotide phosphodiesterase activity in cellular systems by ion pair reversed phase liquid chromatography. J Chromatogr 1989;483:427-430.
27. Tachado SD, Akhtar RA, Zhou CJ, Abdel-Latif AA. Effects of isoproterenol and forskolin on carbachol- and fluoroaluminate-induced polyphosphoinositide hydrolysis, inositol trisphosphate production, and contraction in bovine iris sphincter smooth muscle. Interaction between cAMP and IP3 second messenger systems. Cell Signal 1992;4:61-75.
28. Stoclet JC, Boulanger-Saunier C, Lassegue B, Lugnier C. Cyclic nucleotides and calcium regulation in heart and smooth muscle cells Ann NY Acad Sci 1988;522:106-115.